Publications by authors named "A Zipprich"

Background: Transjugular intrahepatic portosystemic shunt (TIPS) placement leads to a reduction in portal pressure and an improvement in survival in patients with recurrent and refractory ascites and variceal haemorrhage. Prediction of post-TIPS survival is primarily determined by factors identified before the TIPS procedure, as data collected during or after TIPS implantation are limited. The aim of the study was to evaluate the influence of early hemodynamic changes after TIPS placement on survival, in order to refine post TIPS management.

View Article and Find Full Text PDF

Background: Recent studies suggest a contribution of intrahepatic mineralocorticoid receptor (MR) activation to the development of cirrhosis. As MR blockade abrogates the development of cirrhosis and hypoxia, common during the development of cirrhosis, can activate MR in hepatocytes. But, the impact of non-physiological hepatic MR activation is unknown.

View Article and Find Full Text PDF

Patients with cirrhosis-associated and portal hypertension-associated complications may benefit from TIPS and/or liver transplantation. In many patients, the decision of whether or not TIPS should be placed prior to liver transplantation is fairly clear-cut. Nevertheless, there are some patients in whom the decision can be more complex.

View Article and Find Full Text PDF
Article Synopsis
  • NOD2 mutations are linked to decreased gut barrier function, and this study aimed to determine their relation to the first episode of decompensation in patients with compensated cirrhosis.
  • During the analysis of 360 patients, no overall difference in decompensation rates was found between those with and without NOD2 variants, but a notable increase in decompensation was observed in patients with varices carrying these variants.
  • The findings suggest that NOD2 variants might increase the risk of decompensation primarily in patients who already have varices, making MELD and NOD2 status critical predictors in this subgroup.
View Article and Find Full Text PDF

Background: Liver dysfunction is a known risk factor in the cardiovascular field. It specifically increases perioperative risk in patients undergoing coronary bypass surgery. Since percutaneous coronary intervention (PCI) is the much less invasive procedure for the treatment of coronary artery disease, we aimed to assess the relationship of liver dysfunction with outcomes in patients undergoing PCI.

View Article and Find Full Text PDF